Market revenue in 2023 | USD 3.7 million |
Market revenue in 2030 | USD 11.6 million |
Growth rate | 18% (CAGR from 2023 to 2030) |
Largest segment | Pure prp |
Fastest growing segment | Leukocyte Rich PRP |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pure PRP, Leukocyte Rich PRP |
Key market players worldwide | Johnson & Johnson, Arthrex, Terumo Corp, Zimmer Biomet Holdings Inc, Stryker Corp, EmCyte Corporation, Dr. PRP USA, Juventix Regenerative Medical, APEX Biologix, Celling Biosciences |
Pure prp was the largest segment with a revenue share of 51.35% in 2023. Horizon Databook has segmented the Saudi Arabia platelet rich plasma (prp) market based on pure prp, leukocyte rich prp covering the revenue growth of each sub-segment from 2018 to 2030.
Hair loss has been a long-standing concern for men, and it remains a prevalent issue in Saudi Arabia. Alopecia areata exhibits a higher prevalence in Saudi Arabia compared to Western countries, with an earlier age of onset.
This condition tends to affect males more than females, and the onset occurs at a relatively younger age in women. In response to the demand for effective hair loss solutions, PRP hair treatment has become a popular choice in major cities, such as Riyadh and Jeddah.
Saudi Arabia faces a significant health challenge, with one in every four Saudi adults with diabetes mellitus. Moreover, over 44% of individuals aged 55 years and older in the country suffer from long-term complications related to severe or uncontrolled diabetes.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account